Publications in collaboration with researchers from Fukuoka Children's Hospital and Medical Center for Infectious Diseases (1)

2022

  1. Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity

    New England Journal of Medicine